Published in AJNR Am J Neuroradiol on January 09, 2008
Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol Med (2011) 1.16
Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease. Parkinsons Dis (2011) 0.95
ADC histograms from routine DWI for longitudinal studies in cerebral small vessel disease: a field study in CADASIL. PLoS One (2014) 0.86
MRI reveals brain abnormalities in drug-naive Parkinson's disease. Exerc Sport Sci Rev (2014) 0.80
Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson's Disease. Front Aging Neurosci (2016) 0.78
White matter changes in primary dystonia determined by 2D distribution analysis of diffusion tensor images. J Magn Reson Imaging (2012) 0.76
Magnetic resonance imaging markers for early diagnosis of Parkinson's disease. Neural Regen Res (2012) 0.75
Relevance of the skewness index in DTI exploration of multiple sclerosis. MAGMA (2008) 0.75
Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson's Symptoms. Front Aging Neurosci (2017) 0.75
White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol (1995) 2.30
Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol (2004) 1.80
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study. Neurology (2003) 1.60
Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology (2002) 1.51
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia (1994) 1.49
An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography. J Nucl Med (1991) 1.42
Late whiplash syndrome: a clinical and magnetic resonance imaging study. Funct Neurol (2000) 1.41
The cerebellum looks normal in Friedreich ataxia. AJNR Am J Neuroradiol (2013) 1.39
Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol (2007) 1.36
The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2010) 1.30
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci (2005) 1.30
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Screening of lung cancer with low dose spiral CT: results of a three year pilot study and design of the randomised controlled trial ''Italung-CT''. Radiol Med (2005) 1.20
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry (2004) 1.20
Solitary necrotic nodule of the liver: imaging and correlation with pathologic features. Abdom Imaging (2002) 1.17
MR imaging in a case of Hallervorden-Spatz disease. J Comput Assist Tomogr (1987) 1.15
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13
Role of micronutrients in the periconceptional period. Hum Reprod Update (2009) 1.12
Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. J Med Genet (2005) 1.12
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology (2000) 1.11
The "peeking" effect in supervised feature selection on diffusion tensor imaging data. AJNR Am J Neuroradiol (2013) 1.07
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. Dement Geriatr Cogn Disord (2005) 1.06
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord (2001) 1.05
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. Mov Disord (2001) 1.03
Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain (2004) 1.02
Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke (1990) 1.00
Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol (1999) 1.00
Slowly progressive familial dementia with recurrent strokes and white matter hypodensities on CT scan. Ital J Neurol Sci (1992) 0.99
Brain structural damage in Friedreich's ataxia. J Neurol Neurosurg Psychiatry (2007) 0.98
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand (2007) 0.98
Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course. Int Angiol (2010) 0.98
3-D segmentation algorithm of small lung nodules in spiral CT images. IEEE Trans Inf Technol Biomed (2008) 0.98
Symptomatic unruptured capillary telangiectasia of the brain stem: report of three cases and review of the literature. J Neurol Neurosurg Psychiatry (2001) 0.98
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci (2001) 0.97
Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet Cell Genet (1999) 0.97
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol (2001) 0.96
Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study. AJNR Am J Neuroradiol (2010) 0.96
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.96
The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat Disord (2012) 0.96
Whole-brain histogram and voxel-based analyses of diffusion tensor imaging in patients with leukoaraiosis: correlation with motor and cognitive impairment. AJNR Am J Neuroradiol (2007) 0.95
[Spinal hemorrhagic synovial cyst: magnetic resonance features of a case]. Radiol Med (1996) 0.95
Lower cranial nerve palsy due to dissection of the internal carotid artery: CT and MR imaging. J Comput Assist Tomogr (1989) 0.93
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. Acta Neurol Scand (2001) 0.92
Acute and chronic effects of clozapine in essential tremor. Mov Disord (1999) 0.92
Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study. J Neurol (2009) 0.92
A case of sarcoidosis presenting as a non-specific intramedullary lesion. Eur J Neurol (2007) 0.92
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study. Ital J Neurol Sci (1999) 0.91
Improvement of motor function in early Parkinson disease by safinamide. Neurology (2004) 0.91
The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread. J Neurol (2014) 0.91
Hypoactive-hypoalert behavior ("psychic akinesia") in intracranial hypotension syndrome. Neurology (2008) 0.90
Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art. Radiol Med (2012) 0.90
E-learning in radiology: an Italian multicentre experience. Eur J Radiol (2012) 0.90
Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet (1997) 0.90
The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol (1995) 0.90
Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Mov Disord (2000) 0.89
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study. Eur J Neurol (2009) 0.89
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports. J Neurol Neurosurg Psychiatry (2001) 0.88
Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment. AJNR Am J Neuroradiol (2013) 0.87
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy. Parkinsonism Relat Disord (2004) 0.87
Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol (1996) 0.87
Diurnal motor variations to repeated doses of levodopa in Parkinson's disease. Clin Neuropharmacol (2000) 0.87
Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. J Neural Transm (Vienna) (2004) 0.86
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports. Ital J Neurol Sci (1983) 0.86
Amantadine in Huntington's disease: open-label video-blinded study. Neurol Sci (2002) 0.86
Subcortical arteriosclerotic encephalopathy: single photon emission computed tomography-magnetic resonance imaging correlation. Am J Physiol Imaging (1990) 0.85
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia. J Neural Transm (Vienna) (2006) 0.85
Myopathic involvement in two cases of Hallervorden-Spatz disease. Brain Dev (1996) 0.85
MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol (1993) 0.85
Magnetization transfer imaging demonstrates a distributed pattern of microstructural changes of the cerebral cortex in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2011) 0.85
Antinociceptive properties of the methanolic extract obtained from Ipomoea pes-caprae (L.) R. Br. J Ethnopharmacol (2000) 0.85
Headache, panic disorder and depression: comorbidity or a spectrum? Neuropsychobiology (1995) 0.84
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials. Clin Neuropharmacol (1997) 0.84
Structural anomaly of left lateral temporal lobe in epilepsy due to mutated LGI1. Neurology (2007) 0.84
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. Neurology (1995) 0.84
Dexamethasone augmentation in treatment-resistant depression. Acta Psychiatr Scand (1997) 0.84